首页> 外文会议>Progress on post-genome technologies and modern natural products >DIAGNOSTIC VALUES OF COMBINED HEPATOMA-SPECIFIC α-FETOPROTEIN FRACTION AND TELOMERASE IN PATIENTS WITH HEPATOCELLULAR CARCINMA
【24h】

DIAGNOSTIC VALUES OF COMBINED HEPATOMA-SPECIFIC α-FETOPROTEIN FRACTION AND TELOMERASE IN PATIENTS WITH HEPATOCELLULAR CARCINMA

机译:肝细胞癌患者中特定于肝细胞的α-FET蛋白成分和端粒酶联合的诊断价值

获取原文
获取原文并翻译 | 示例

摘要

Hepatocellular carcinoma (HCC) prognosis is poor and early detection is of the utmost importance. In the present study, the telomerase activities and hepatoma-specific AFP (HS-AFP) levels of peripheral blood we investigated in various kinds of liver disease patients. Our data indicated that the expression of AFP-L3% or telomerase in HCC group was significantly higher (P<0. 01) than that in cirrhosis, chronic hepatitis and normal control group. No significant relationship was found between AFP-L3% or telomerase and Total AFP, except of HCC metastasis and relapse and suggested that quantification of circulating telomerase expression and AFP-L3 level are overexpressed in HCC, indicated that the analysis of AFP-L3% or telomerase are useful markers to diagnose and differentiate HCC or monitor metastasis and relapse of HCC.
机译:肝细胞癌(HCC)的预后很差,早期发现至关重要。在本研究中,我们调查了各种肝病患者的外周血端粒酶活性和肝癌特异性AFP(HS-AFP)水平。我们的数据表明,HCC组中AFP-L3%或端粒酶的表达明显高于肝硬化,慢性肝炎和正常对照组(P <0。01)。除HCC转移和复发外,未发现AFP-L3%或端粒酶与总AFP之间有显着相关性,提示HCC中循环端粒酶表达和AFP-L3水平的定量过表达,表明对AFP-L3%或AFP-L3%的分析端粒酶是诊断和区分HCC或监测HCC转移和复发的有用标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号